ANDA 75769, held by Eugia Pharma Speclts. Dipyridamole.
As of Nov 15, 2026, ANDA 75769 (Dipyridamole), held by Eugia Pharma Speclts, was first approved by FDA on Nov 27, 2002, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Nov 27, 2002 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Dipyridamole5MG/ML ยท injectable;injection | Dipyridamole | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
